Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

718 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Long-term safety and efficacy results of once-daily emtricitabine-based highly active antiretroviral therapy regimens in human immunodeficiency virus-infected pediatric subjects.
Saez-Llorens X, Violari A, Ndiweni D, Yogev R, Cashat M, Wiznia A, Chittick G, Harris J, Hinkle J, Blum MR, Adda N, Rousseau F; FTC-203 Study Team. Saez-Llorens X, et al. Among authors: rousseau f. Pediatrics. 2008 Apr;121(4):e827-35. doi: 10.1542/peds.2006-3078. Epub 2008 Mar 10. Pediatrics. 2008. PMID: 18332076 Clinical Trial.
Intracellular pharmacology of emtricitabine and tenofovir.
Stevens RC, Blum MR, Rousseau FS, Kearney BP. Stevens RC, et al. Clin Infect Dis. 2004 Sep 15;39(6):877-8; author reply 878-9. doi: 10.1086/423810. Clin Infect Dis. 2004. PMID: 15472830 No abstract available.
Severe hepatotoxicity associated with nevirapine use in HIV-infected subjects.
Sanne I, Mommeja-Marin H, Hinkle J, Bartlett JA, Lederman MM, Maartens G, Wakeford C, Shaw A, Quinn J, Gish RG, Rousseau F. Sanne I, et al. Among authors: rousseau f. J Infect Dis. 2005 Mar 15;191(6):825-9. doi: 10.1086/428093. Epub 2005 Feb 10. J Infect Dis. 2005. PMID: 15717255 Clinical Trial.
Clinical trial: a phase II, randomized study evaluating the safety, pharmacokinetics and anti-viral activity of clevudine for 12 weeks in patients with chronic hepatitis B.
Lim SG, Leung N, Hann HW, Lau GK, Trepo C, Mommeja-Marin H, Moxham C, Sorbel J, Snow A, Blum MR, Rousseau F, Marcellin P. Lim SG, et al. Among authors: rousseau f. Aliment Pharmacol Ther. 2008 Jun;27(12):1282-92. doi: 10.1111/j.1365-2036.2008.03686.x. Epub 2008 Mar 22. Aliment Pharmacol Ther. 2008. PMID: 18363895 Free article. Clinical Trial.
A phase II dose-escalating trial of clevudine in patients with chronic hepatitis B.
Marcellin P, Mommeja-Marin H, Sacks SL, Lau GK, Sereni D, Bronowicki JP, Conway B, Trepo C, Blum MR, Yoo BC, Mondou E, Sorbel J, Snow A, Rousseau F, Lee HS. Marcellin P, et al. Among authors: rousseau f. Hepatology. 2004 Jul;40(1):140-8. doi: 10.1002/hep.20257. Hepatology. 2004. PMID: 15239097 Clinical Trial.
718 results